NCT00514163View on ClinicalTrials.gov

GEM vs GEM+TS-1 for Advanced Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2010

Study Completion Date

December 31, 2010

Conditions
Pancreatic Cancer
Interventions
DRUG

gemcitabine + S-1

gemcitabine on day one and 8th S-1 po days 1 to14 every 3 weeks

DRUG

gemcitabine

gemcitabine DIV on day one , 8th and 15th

Trial Locations (1)

135-8550

Cancer Institute Ariake Hospital, Tokyo

All Listed Sponsors
lead

Japan Clinical Cancer Research Organization

OTHER

NCT00514163 - GEM vs GEM+TS-1 for Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter